Harald Herrmann, Sabine Cerny-Reiterer, Karoline V. Gleixner, Katharina Blatt, Susanne Herndlhofer, Werner Rabitsch, Eva Jäger, Gerlinde Mitterbauer-Hohendanner, Berthold Streubel, Edgar Selzer, Ilse Schwarzinger, Wolfgang R. Sperr, and Peter Valent. 2012. “CD34+/CD38− Stem Cells in Chronic Myeloid Leukemia Express Siglec-3 (CD33) and Are Responsive to the CD33-Targeting Drug gemtuzumab/Ozogamicin”. Haematologica 97 (2). Pavia, Italy, 219-26. https://doi.org/10.3324/haematol.2010.035006.